Lv11
40 积分 2024-07-18 加入
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
3小时前
待确认
Cis interactions between CD2 and its ligands on T cells are required for T cell activation
2天前
已完结
Stabilization of adalimumab Fab through the introduction of disulfide bonds between the variable and constant domains
1个月前
已完结
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
1个月前
已完结
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
1个月前
已完结
The effect of foetal bovine serum supplementation upon the lactate dehydrogenase cytotoxicity assay: Important considerations for in vitro toxicity analysis
2个月前
已完结
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
2个月前
已完结
Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom
4个月前
已完结
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
6个月前
已完结
TERT activation targets DNA methylation and multiple aging hallmarks
7个月前
已完结
皖公网安备34019202002308
